National Immunization Campaigns With Oral Polio Vaccine May Reduce All-cause Mortality: An Analysis of 13 Years of Demographic Surveillance Data From an Urban African Area
- PMID: 32949460
- DOI: 10.1093/cid/ciaa1351
National Immunization Campaigns With Oral Polio Vaccine May Reduce All-cause Mortality: An Analysis of 13 Years of Demographic Surveillance Data From an Urban African Area
Abstract
Background: Between 2002 and 2014, Guinea-Bissau had 17 national campaigns with oral polio vaccine (OPV) as well as campaigns with vitamin A supplementation (VAS), measles vaccine (MV), and H1N1 influenza vaccine. We examined the impact of these campaigns on child survival.
Methods: We examined the mortality rate between 1 day and 3 years of age of all children in the study area. We used Cox models with age as underlying time to calculate adjusted mortality rate ratios (MRRs) between "after-campaign" mortality and "before-campaign" mortality, adjusted for temporal change in mortality and stratified for season at risk.
Results: Mortality was lower after OPV-only campaigns than before, with an MRR for after-campaign vs before-campaign being 0.75 (95% confidence interval [CI], .67-.85). Other campaigns did not have similar effects, the MRR being 1.22 (95% CI, 1.04-1.44) for OPV + VAS campaigns, 1.39 (95% CI, 1.20-1.61) for VAS-only campaigns, 1.32 (95% CI, 1.09-1.60) for MV + VAS campaigns, and 1.13 (95% CI, .86-1.49) for the H1N1 campaign. Thus, all other campaigns differed significantly from the effect of OPV-only campaigns. Effects did not differ for trivalent, bivalent, or monovalent strains of OPV. With each additional campaign of OPV only, the mortality rate declined further (MRR, 0.86 [95% CI, .81-.92] per campaign). With follow-up to 3 years of age, the number needed to treat to save 1 life with the OPV-only campaign was 50 neonates.
Conclusions: OPV campaigns can have a much larger effect on child survival than otherwise assumed. Stopping OPV campaigns in low-income countries as part of the endgame for polio infection may increase child mortality.
Keywords: OPV; campaigns; eradication; nonspecific/heterologous effects of vaccines; oral polio vaccine.
© The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.
Similar articles
-
Research protocol of two concurrent cluster-randomized trials: Real-life Effect of a CAMPaign with Measles Vaccination (RECAMP-MV) and Real-life Effect of a CAMPaign with Oral Polio Vaccination (RECAMP-OPV) on mortality and morbidity among children in rural Guinea-Bissau.BMC Public Health. 2019 Nov 11;19(1):1506. doi: 10.1186/s12889-019-7813-y. BMC Public Health. 2019. PMID: 31711464 Free PMC article.
-
National Immunization Campaigns with Oral Polio Vaccine Reduce All-Cause Mortality: A Natural Experiment within Seven Randomized Trials.Front Public Health. 2018 Feb 2;6:13. doi: 10.3389/fpubh.2018.00013. eCollection 2018. Front Public Health. 2018. PMID: 29456992 Free PMC article.
-
Does oral polio vaccine have non-specific effects on all-cause mortality? Natural experiments within a randomised controlled trial of early measles vaccine.BMJ Open. 2016 Dec 23;6(12):e013335. doi: 10.1136/bmjopen-2016-013335. BMJ Open. 2016. PMID: 28011813 Free PMC article. Clinical Trial.
-
Polio endgame: the global switch from tOPV to bOPV.Expert Rev Vaccines. 2016 Jun;15(6):693-708. doi: 10.1586/14760584.2016.1140041. Epub 2016 Feb 2. Expert Rev Vaccines. 2016. PMID: 26751187 Review.
-
Stopping live vaccines after disease eradication may increase mortality.Vaccine. 2020 Jan 3;38(1):10-14. doi: 10.1016/j.vaccine.2019.10.034. Epub 2019 Oct 21. Vaccine. 2020. PMID: 31648913 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical